Market Overview

Benzinga's Top Upgrades

Related FNSR
UPDATE: RBC Capital Upgrades Finisar
Benzinga's Top Upgrades
Related THC
Updated Research Report on Tenet Healthcare - Analyst Blog
What Makes Tenet (THC) a Strong Sell? - Tale of the Tape

Analysts at Jefferies upgraded Finisar (NASDAQ: FNSR) from “underperform” to “hold.” The target price for Finisar has been raised from $11.50 to $22.50. Finisar's shares closed at $23.54 yesterday.

Stifel Nicolaus upgraded Cloud Peak Energy (NYSE: CLD) from “hold” to “buy.” Cloud Peak Energy's shares closed at $14.57 yesterday.

Analysts at Goldman Sachs upgraded Tenet Healthcare (NYSE: THC) from “neutral” to “buy.” The target price for Tenet Healthcare has been raised from $47 to $55. Tenet Healthcare's shares closed at $46.10 yesterday.

Analysts at Morgan Stanley upgraded ABB (NYSE: ABB) from “underweight” to “equal-weight.” ABB's shares closed at $23.24 yesterday.

Posted-In: top upgradesUpgrades Analyst Ratings

 

Most Popular

Related Articles (ABB + CLD)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free